B. J. Gertz

2.1k citations

27 papers · 1.7k indexed · h-index 21

Oncology top 5%
Orthopedics and Sports Medicine top 1%
Endocrinology, Diabetes and Metabolism top 5%
Molecular Biology
Physiology top 10%

Co-authors: Sherry D. Holland C. H. Chesnut Harry K. Genant Steven T. Harris David Krupa Arturo G. Porras Johanna Wittreich B.K. Matuszewski
Topics: Bone health and treatments (10 papers)Bone health and osteoporosis research (7 papers)Growth Hormone and Insulin-like Growth Factors (6 papers)
Cited by: Orthopedics and Sports Medicine Endocrine and Autonomic Systems Endocrinology, Diabetes and Metabolism
Journals: Journal of Clinical Investigation Journal of Clinical Oncology The Journal of Clinical Endocrinology & Metabolism
Partner nations: United States United Kingdom Belgium

In The Last Decade

B. J. Gertz

26 papers receiving 1.6k citations

Peers

Countries citing papers authored by B. J. Gertz

Since Specialization

Citations

This map shows the geographic impact of B. J. Gertz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. J. Gertz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. J. Gertz more than expected).

Fields of papers citing papers by B. J. Gertz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. J. Gertz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. J. Gertz. The network helps show where B. J. Gertz may publish in the future.

Co-authorship network of co-authors of B. J. Gertz

This figure shows the co-authorship network connecting the top 25 collaborators of B. J. Gertz. A scholar is included among the top collaborators of B. J. Gertz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. J. Gertz. B. J. Gertz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effects of Etoricoxib and Comparator Nonsteroidal Anti‐Inflammatory Drugs on Urinary Sodium Excretion, Blood Pressure, and Other Renal Function Indicators in Elderly Subjects Consuming a Controlled Sodium Diet 2007 ·The Journal of Clinical Pharmacology ·(unknown),Chau Thach,(unknown),Jutta Miller,David Hreniuk,(unknown),(unknown),B. J. Gertz,(unknown)	16
2	Effect of high-fat breakfast and moderate-fat evening meal on the pharmacokinetics of vardenafil, a potent, highly selective PDE-5 inhibitor for the treatment of erectile dysfunction 2002 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Jules I. Schwartz,Arturo G. Porras,Peggy H. Wong,Anne Van Hecken,(unknown),(unknown),Thomas R. Hunt,David L. Ebel,(unknown),(unknown),B. J. Gertz,(unknown)	0
3	Effect of Alendronate and MK-677 (a Growth Hormone Secretagogue), Individually and in Combination, on Markers of Bone Turnover and Bone Mineral Density in Postmenopausal Osteoporotic Women¹ 2001 ·The Journal of Clinical Endocrinology & Metabolism ·M. Gail Murphy,(unknown),Michael R. McClung,Thomas J. Schnitzer,K. Cerchio,Jennie Connor,David Krupa,B. J. Gertz	67
4	Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis 2001 ·European Journal of Cancer ·V. Cocquyt,Simon Van Belle,Robert Reinhardt,Marc Decramer,Mary O’Brien,Jan H.M. Schellens,(unknown),Len Verbeke,F. Van Aelst,M. De Smet,A. Carides,(unknown),B. J. Gertz	116
5	Single dose methodology to assess the influence of an α₁‐adrenoceptor antagonist on uroflowmetric parameters in patients with benign prostatic hyperplasia 2000 ·British Journal of Clinical Pharmacology ·Sean Curtis,Ian Eardley,Malcolm Boyce,(unknown),(unknown),Keith Gottesdiener,B. J. Gertz	4
6	Pharmacokinetics, COX-2 specificity, and tolerability of supratherapeutic doses of rofecoxib in humans 2000 ·European Journal of Clinical Pharmacology ·Marleen Depré,Elliot Ehrich,Anne Van Hecken,Inge De Lepeleire,(unknown),Peggy Wong,Arturo G. Porras,B. J. Gertz,P.J. De Schepper	78
7	Oral Administration of the Growth Hormone Secretagogue MK-677 Increases Markers of Bone Turnover in Healthy and Functionally Impaired Elderly Adults 1999 ·Journal of Bone and Mineral Research ·M. Gail Murphy,Mark A. Bach,D. Plotkin,(unknown),Jennifer Ng,David Krupa,K. Cerchio,B. J. Gertz	39
8	Application of a New Serum Assay for Type I Collagen Cross-Linked N-Telopeptides: Assessment of Diurnal Changes in Bone Turnover With and Without Alendronate Treatment 1998 ·Calcified Tissue International ·B. J. Gertz,John D Clemens,Sherry D. Holland,Wenmin Yuan,S. L. Greenspan	96
9	Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile. 1997 ·PubMed ·Suresh K. Balani,Xin Xu,Vijaya S. Pratha,Michael A. Koss,Raju D. Amin,C. DUFRESNE,R R Miller,Byron H. Arison,George A. Doss,Masato Chiba,Amanda Freeman,Sherry D. Holland,Jules I. Schwartz,Kenneth C. Lasseter,B. J. Gertz,Jon I. Isenberg,John Rogers,Jiunn H. Lin,Thomas A. Baillie	75
10	Rationale for the use of alendronate in osteoporosis 1995 ·Osteoporosis International ·John А. Kanis,B. J. Gertz,Frederick R. Singer,S. Ortolani	60
11	Neuroendocrine responses to a novel growth hormone secretagogue, L-692,429, in healthy older subjects. 1994 ·The Journal of Clinical Endocrinology & Metabolism ·Joseph Aloi,B. J. Gertz,Mark L. Hartman,(unknown),Suzan S. Pezzoli,Johanna Wittreich,David Krupa,Michael O. Thorner	58
12	Monitoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urine 1994 ·Journal of Bone and Mineral Research ·B. J. Gertz,Ping Shao,Dennis A. Hanson,Hui Quan,Steven T. Harris,Harry K. Genant,C. H. Chesnut,David R. Eyre	172
13	The effect of short term treatment with alendronate on vertebral density and biochemical markers of bone remodeling in early postmenopausal women. 1993 ·The Journal of Clinical Endocrinology & Metabolism ·Steven T. Harris,B. J. Gertz,Harry K. Genant,David W. Eyre,(unknown),(unknown),(unknown),(unknown),C. H. Chesnut	148
14	Dose-response study of alendronate sodium for the treatment of cancer-associated hypercalcemia. 1993 ·Journal of Clinical Oncology ·S R Nussbaum,Raymond P. Warrell,Robert K. Rude,J. E. Glusman,J P Bilezikian,Andrew F. Stewart,(unknown),(unknown),Steven D. Averbuch,B. J. Gertz	45
15	Clinical pharmacology of alendronate sodium 1993 ·Osteoporosis International ·B. J. Gertz,Sherry D. Holland,W. F. Kline,B.K. Matuszewski,Arturo G. Porras	129
16	Comparison of a rapid (2-h) versus a slow (24-h) infusion of alendronate in the treatment of hypercalcemia of malignancy 1992 ·Bone and Mineral ·(unknown),Patrick Ammann,(unknown),B. J. Gertz,Luc Portmann,René Rizzoli,(unknown),(unknown),J.‐P. Bonjour,P. Burckhardt	22
17	Effects of five daily 1 h infusions of alendronate in paget's disease of bone 1992 ·Journal of Bone and Mineral Research ·D.P. O’Doherty,B. J. Gertz,W. B. Tindale,David Sciberras,(unknown),John А. Kanis	34
18	Inhibition of Cholecystokinin-Stimulated Pancreaticobiliary Output in Man by the Cholecystokinin Receptor Antagonist MK-329 1991 ·Scandinavian Journal of Gastroenterology ·P. Cantor,Ole Olsen,B. J. Gertz,Ida Gjørup,H. Worning	22
19	Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK. 1989 ·Journal of Clinical Investigation ·Rodger A. Liddle,B. J. Gertz,S Kanayama,(unknown),(unknown),(unknown),Eugene Morita	127
20	Gene for the rat atrial natriuretic peptide is regulated by glucocorticoids in vitro. 1988 ·Journal of Clinical Investigation ·David G. Gardner,B. J. Gertz,Christian F. Deschepper,(unknown)	68

About B. J. Gertz

B. J. Gertz is a scholar working on Orthopedics and Sports Medicine, Endocrinology, Diabetes and Metabolism and Biochemistry, having authored 27 papers that have together received 1.7k indexed citations. Recurring topics across this work include Bone health and treatments (10 papers), Bone health and osteoporosis research (7 papers) and Growth Hormone and Insulin-like Growth Factors (6 papers). The work is most often cited by research in Orthopedics and Sports Medicine (525 citations), Endocrine and Autonomic Systems (190 citations) and Endocrinology, Diabetes and Metabolism (373 citations). B. J. Gertz has collaborated with scholars based in United States, United Kingdom and Belgium. Frequent co-authors include Sherry D. Holland, C. H. Chesnut, Harry K. Genant, Steven T. Harris, David Krupa, Arturo G. Porras, Johanna Wittreich, B.K. Matuszewski, W. F. Kline and M. Gail Murphy. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and The Journal of Clinical Endocrinology & Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact